Everything’s better and we can all relax now – or at least, that’s what you might think if you only take a superficial look at the major stock market indexes. Beneath the bullish veneer is another rising wave of Covid cases around the world, and investors need to respond accordingly.
The statistics should put any market trader on high alert:
- Covid-19 infections have been rising at an alarming rate for eight consecutive weeks.
- Covid-related deaths increased for the fifth straight week, with the pandemic now officially claiming more than 3 million lives.
- More than 5.2 million new cases were recorded last week – the most in a single week since the pandemic began – according to WHO Director-General Tedros Adhanom Ghebreyesus.
- It only took three months to reach 3 million deaths. That’s a rapid pickup in the pace as it took nine months to reach 1 million Covid deaths and four months to reach 2 million deaths.
- India is currently reporting about 294,000 infections and 2,000 deaths per day.
- CDC Director Rochelle Walensky revealed that the seven-day average of new Covid-19 cases in the U.S. is at more than 67,443, up 1% from the prior seven-day average of 66,702. Four weeks ago, the seven-day average was 53,000 cases a day.
- The CDC also reports that the seven-day average number of new Covid-19 infections has eclipsed the 14-day average in about half the country, with 40 states hitting that benchmark.
Questions about the efficacy and safety of Covid-19 vaccines have contributed to the issue. For instance, a mass vaccination center in the southern French city of Nice was forced to close early recently after just 58 people turned up for 4,000 doses of the AstraZeneca vaccine.
So, what does all of this mean for investors? If you’re a true contrarian, then you’ll appreciate the mismatch between certain stocks which can benefit from troubling circumstances, and the market’s unwillingness to recognize the hazards that lie ahead of us.
One example would be Utah-headquartered Co-Diagnostics (stock ticker symbol: CODX). Co-Diagnostics manufactures diagnostic tests for Covid-19 and other conditions like tuberculosis and hepatitis B and C.
93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.
Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!
Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!
An independent, peer-reviewed paper published in the Journal of Medical Microbiology recently demonstrated a high analytical sensitivity level for Co-Diagnostics’ Logix Smart Covid-19 test kit.
Yet, CODX stock is close to its 52-week low price. And the last time I checked, CODX stock has a P/E ratio of just 5.73, indicating a bargain valuation.
A similar pick is Alpha Pro Tech (APT), which has a P/E ratio of 5.1. Alpha Pro Tech is a Canadian company that sells face masks and shields, lab coats, shoe covers, and other personal protective equipment.
APT Stock. Courtesy: Yahoo Finance
The company appears to mainly target laboratories, hospitals, and businesses in general rather than individual consumers. And again, I’m keeping my eye on APT stock now because it’s close to its 52-week low.
For a completely different pandemic play, you might want to consider DoorDash (DASH) stock. This company is basically an on-demand food delivery service that lets you order food and drinks from restaurants in your area. When you order from DoorDash, the food is delivered by a freelance worker who doesn’t belong to any particular restaurant.
Investors have ploughed almost $14 billion into on-demand grocery delivery services globally since the beginning of the pandemic, according to PitchBook Data. Amazingly, more funding was poured into this sector during the first three months of 2021 than the whole of last year.
If variant Covid-19 strains induce renewed lockdowns, then DASH stock – which is much closer to its 52-week low than its 52-week high price – could promptly return to its peak levels from 2020.
Finally, here’s one more pandemic pick which you probably didn’t expect: Nintendo (NTDOY). Remember how both kids and grown-ups stayed indoors for hours on end, playing videos games during the first Covid-19 wave?
Well, another wave could easily lead to another scale-up in the video game market – and of course, Nintendo is a recognized name in that sector with no shortage of addictive games.
As for the shares, NTDOY stock is trading at a very reasonable P/E ratio of 17.15. At the same time, the stock pays an annual dividend yield of 2.65%, which you can collect while you’re cooped up indoors if there’s another forced lockdown scenario.
Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!
Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!
Legal Notice: No matter how good an investment sounds, and no mater who is selling it, make sure you’re dealing with a registered investment professional. Use the free, simple search at investor.gov
We are not brokers, investment or financial advisers, and you should not rely on the information herein as investment advice. We are a marketing company. If you are seeking personal investment advice, please contact a qualified and registered broker, investment adviser or financial adviser. You should not make any investment decisions based on our communications. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT recommendations. The securities issued by the companies we profile should be considered high risk and, if you do invest, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEC filings, press releases, and risk disclosures. Information contained in this profile was provided by the company, extracted from SEC filings, company websites, and other publicly available sources. We believe the sources and information are accurate and reliable but we cannot guarantee it.
Please read our full disclaimer at CrushTheStreet.com/disclaimer